Romania's Competition Council investigates big pharma groups

Romania’s Competition Council has initiated an investigation at Novartis Pharma Services Romania, the local subsidiary of the Swiss pharma group Novartis. The investigation targets a possible abuse of dominant position by implementing a pilot project for direct distribution to certain pharmacies. Novartis ranks second in Romania’s pharma sector, with sales of EUR 140 million in 2015 and a market share of 5.5%. The Competition Council is also investigating British group GSK’s local subsidiary for a possible breach of the competition law. The Competition Council published yesterday a report following a sectorial analysis of the pharma market. editor@romania-insider.com